Skip to main content
MintRx

Sexual Health

Best libido support treatments compared

Compare low-desire treatments, counseling, vaginal care and erection medicines. Learn what fits your symptoms and what to ask before choosing.

Written by MintRx Clinical TeamPublished November 17, 2026
Best libido support treatments compared

Reviewer: Nathan Parker, PharmD.

Start with what you want to feel different. Is the interest missing? Is sex uncomfortable? Or is your body not responding the way you want it to? The best libido support treatment depends on that answer. Counseling, vaginal care, medicines for distressing low desire and erection treatments each have a different job.

Getting an erection, wanting sex and feeling comfortable during sex are connected, but they aren't interchangeable. Getting clear on the part that's bothering you makes it much easier to compare your options.

Start with what feels different

Desire is interest in sex. Arousal includes feeling mentally excited and the body's physical response to stimulation. Pain or dryness can make sexual activity uncomfortable, even when the interest is there. Erection difficulties mean trouble getting or keeping an erection. These concerns can overlap, but one treatment may not address all of them.

Low desire alone does not automatically mean you have a disorder. Desire can develop after intimacy begins. What matters is whether the change bothers you, when it started and what else was happening. ACOG's guide to sexual health explains common contributors, including medicines, stress and hormonal changes.

This compares treatment categories, not just MintRx products. Naming Addyi and Vyleesi here does not mean MintRx offers them.

Compare the options by the job they need to do

Main concern Option worth discussing What changes the decision
Stress, anxiety or relationship patterns affecting intimacy Counseling or sex therapy, with medical care when needed Addresses barriers a prescription alone may not resolve
Distressing low desire across situations Flibanserin (Addyi) or bremelanotide injection (Vyleesi), when the diagnosis and indication fit Different eligible populations, daily versus as-needed use, and different safety considerations
Persistent low desire after menopause A full assessment, including whether transdermal testosterone fits Evidence supports selected women with HSDD; treatment requires monitoring and is off-label in the U.S.
Vaginal dryness or pain Lubricants, moisturizers and evaluation for targeted vaginal treatment Comfort is the treatment goal, not automatically increasing desire
Erection difficulties Sildenafil or tadalafil Supports the erection response during sexual stimulation
A specific formulation need or a proposed compounded product Review the exact ingredients, route and rationale Product names do not tell you which symptom or evidence applies

Counseling and medication review are real treatment choices

If interest changes with stress, anxiety or relationship circumstances, counseling or sex therapy may help. That does not mean your symptoms are imaginary. Counseling can accompany medical treatment rather than compete with it.

Tell the care team if the change began after starting a medicine, including an antidepressant. Reviewing that timeline may be more useful than adding another product. Do not stop an existing prescription on your own.

Medicines specifically for distressing low desire

When low desire is persistent and upsetting, a clinician may assess for hypoactive sexual desire disorder, or HSDD. Addyi and Vyleesi are intended for a specific pattern: the low desire developed after a period without the problem, happens across situations, and isn't explained by another medical or psychiatric condition, a relationship problem or a medicine's effects.

Flibanserin (Addyi) takes a daily approach. You take it at bedtime, rather than just before sex. Its current prescribing information covers women younger than 65 with that pattern of HSDD, including eligible women after menopause. It isn't a treatment for men or a general performance enhancer.

Before choosing Addyi, work through your medicines, liver health and alcohol use with the pharmacist. Certain medicine interactions and liver impairment rule it out, and the alcohol precautions matter because of low blood pressure and fainting. Dizziness and sleepiness can also affect how it fits your routine. If desire hasn't improved after eight weeks, the label directs stopping rather than continuing indefinitely.

Bremelanotide injection (Vyleesi) takes a different approach: as-needed use rather than a daily tablet. It's for premenopausal women with that pattern of HSDD. In placebo-controlled studies, women reported improved desire and less distress about low desire. The number of satisfying sexual events did not significantly improve over placebo. That distinction helps set a useful goal: discuss changes in desire and distress, not a promised number of sexual experiences.

Vyleesi must not be used with uncontrolled high blood pressure or known cardiovascular disease. Nausea is common, blood pressure can rise temporarily, and skin darkening may persist. Discuss pregnancy plans and contraception before treatment, and stop and contact the prescriber if pregnancy is suspected. Its label also directs stopping after eight weeks without improvement.

Neither option is best for everyone. A compounded PT-141 prescription is a separate preparation: our PT-141 injection versus Vyleesi comparison explains the practical differences.

Where hormones fit, and where they don't

Menopause is a natural transition. That does not mean you have to accept symptoms that are making intimacy uncomfortable or upsetting.

Testosterone may be worth discussing when persistent low desire after menopause is the concern. For selected women with HSDD, testosterone delivered through the skin has evidence of a moderate benefit for desire and related distress. The ISSWSH clinical guideline recommends looking at the whole picture first. A testosterone result alone doesn't tell you why desire has changed or which treatment will help.

In the U.S., this use is off-label. Follow-up checks how you feel, testosterone levels and changes such as acne or increased facial hair; long-term safety remains uncertain. For HSDD specifically, the guideline does not recommend compounded testosterone because the evidence for benefit, safety and consistent concentration is insufficient. Ask how the proposed preparation and monitoring fit your situation.

If dryness or pain is the main barrier, the next step may be local vaginal care instead. Lubricants reduce friction during sex; moisturizers address ongoing dryness. For menopause-related vaginal symptoms, vaginal estrogen is an established treatment option, including for some people already using systemic HRT. Other vaginal treatments may be considered when the first approach is unsuitable or not helping. New pain or bleeding needs assessment rather than an assumption that it is menopause.

Our guide to local versus systemic hormone therapy explains why improving hot flashes does not always resolve vaginal discomfort. Neither approach is a universal libido treatment.

If the problem is erections, compare erection treatments

Sildenafil and tadalafil support blood flow during sexual stimulation. They have an established role in erectile dysfunction, but neither is an established treatment for low desire itself. If erection reliability is the main issue, our ED treatment comparison is the more useful next read.

Do not use sildenafil or tadalafil with nitrates, recreational nitrites called poppers, or riociguat. These precautions apply to combination products containing those ingredients too. The sildenafil label and tadalafil label explain the interactions. An erection lasting four hours requires emergency care. Stop the medicine and seek medical care right away for sudden vision or hearing loss.

Compare compounded products by their ingredients, not their names

Compounding can meet a medical need an appropriate manufactured product does not, such as a needed dosage form or avoiding an ingredient. Ask: why this preparation for this concern?

MintRx's Libido Lift Dissolvable combines L-citrulline 200 mg, oxytocin 200 IU and tadalafil 10 mg in a sublingual troche. Those ingredients matter more than the product name: this is not testosterone or estrogen therapy, and the combination has not been established as a treatment for HSDD. The tadalafil also means you need the same interaction review discussed above. Do not use it during pregnancy or when planning pregnancy, or add sildenafil or tadalafil without prescriber review.

MintRx's PT-141 nasal spray contains bremelanotide 5 mg/mL. If you prefer a nasal spray, ask what benefit to expect from this preparation and how you'll judge whether it's helping. The Vyleesi injection studies don't establish the spray's benefit, timing or side-effect rates. MintRx says not to use this nasal product with uncontrolled high blood pressure, heart disease, pregnancy or breastfeeding. Discuss pregnancy plans with the prescriber and follow your own label; injection directions cannot be converted into sprays.

Compounded medicines are not FDA-approved or reviewed by FDA for safety, effectiveness or quality before marketing. FDA's explanation of compounding describes their role when a patient needs a preparation an appropriate approved product cannot provide. The useful question is why this formula fits your needs and how you'll follow up on the result.

Make the next conversation specific

Bring what changed, when it started, what you've tried and what you want to be different. Include all medicines and supplements. If you already use a prescription, bring the actual label and describe how you've used it, for how long, what helped and what did not.

At follow-up, get more specific than 'Did it work?' Are you more interested in sex? More comfortable? Is the physical response better? What is still getting in the way? Those answers help the care team decide whether to address the routine, unwanted effects or another cause, rather than simply reaching for a stronger prescription.

MintRx's hormone care model is built around listening over time and working with the prescriber as needs change. The question is: what are we trying to improve, and how will we know whether the plan is helping?

You can explore MintRx's sexual-health options or talk with a MintRx pharmacist. A licensed provider makes prescribing decisions. Here's what happens after treatment starts.

FAQ

Is there one best libido medicine?

No. The first distinction is whether you need help with desire, arousal, comfort or erections. If low desire is persistent and distressing, ask about assessment for HSDD rather than assuming an erection medicine or a hormone is the answer.

Can treatment for painful sex help intimacy without directly increasing desire?

Yes. Reducing discomfort can remove a barrier to intimacy. That is different from proving that a treatment directly increases desire. Persistent pain still needs its own assessment.

Does low desire mean I need testosterone?

Not automatically. Testosterone can be considered for selected women with HSDD after a full assessment, with the strongest evidence in postmenopausal women. A low lab result alone does not make the diagnosis, and treatment needs monitoring.

Sources

Keep reading

Best Libido Support Treatments Compared | MintRx